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Age-related diseasePeroxisomes are cell organelles that play a central role in lipid metabolism. At the same time, these organelles
generate reactive oxygen and nitrogen species as byproducts. Peroxisomes also possess intricate protective
mechanisms to counteract oxidative stress and maintain redox balance. An imbalance between peroxisomal
reactive oxygen species/reactive nitrogen species production and removal may possibly damage biomole-
cules, perturb cellular thiol levels, and deregulate cellular signaling pathways implicated in a variety of
human diseases. Somewhat surprisingly, the potential role of peroxisomes in cellular redox metabolism
has been underestimated for a long time. However, in recent years, peroxisomal reactive oxygen species/
reactive nitrogen species metabolism and signaling have become the focus of a rapidly evolving and multidis-
ciplinary research ﬁeld with great prospects. This review is mainly devoted to discuss evidence supporting
the notion that peroxisomal metabolism and oxidative stress are intimately interconnected and associated
with age-related diseases. We focus on several key aspects of how peroxisomes contribute to cellular reactive
oxygen species/reactive nitrogen species levels in mammalian cells and how these cells cope with
peroxisome-derived oxidative stress. We also provide a brief overview of recent strategies that have been
successfully employed to detect and modulate the peroxisomal redox status. Finally, we highlight some
gaps in our knowledge and propose potential avenues for further research. This article is part of a Special
Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in Health and Disease.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Over the past decades, free radicals and other reactive small mol-
ecules have emerged as important regulators of many physiological
and pathological processes [1,2]. Currently, it is well established
that – at physiological low levels – reactive oxygen species (ROS)
and reactive nitrogen species (RNS) serve as signaling messengers
to mediate various biological responses, including gene expression,
cell proliferation, angiogenesis, innate immunity, programmed cell
death, and senescence [3,4]. On the other hand, it is also known that
increased levels of these short-lived reactive molecules can exert
harmful effects by causing oxidative damage to biological macromol-
ecules and disrupting the cellular reduction–oxidation (redox) bal-
ance [3,5]. A disturbance of ROS/RNS homeostasis is generally
considered as a risk factor for the initiation and progression of dis-
eases such as atherosclerosis, diabetes, neurodegeneration, and can-
cer [5,6]. Whether the effects of ROS/RNS are beneﬁcial or harmfulan ﬂuorescent protein; EC number,
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rights reserved.depends on the site, type, and amount of ROS/RNS production and
the activity of the organism's antioxidant defense system [7].
Endogenous ROS/RNS can be generated as the primary function of
an enzyme system (e.g. NADPH oxidases that are activated in response
to activated receptors), as a byproduct of other biological reactions (e.g.
the mitochondrial electron transport chain), or by metal-catalyzed oxi-
dations (e.g. the Fenton reaction: Fe2++H2O2→Fe3++ •OH+−OH)
[8]. The primary ROS/RNS species generated in a cell are superoxide
(O2•−), hydrogen peroxide (H2O2), and nitric oxide (NO•) [2]. These
molecules can readily react to form other ROS and RNS species. For ex-
ample, O2•− can rapidly react with NO• to form peroxynitrite (ONOO−)
or dismutate to form H2O2, and the latter compound can be decom-
posed through the Fenton reaction leading to the generation of hydrox-
yl radicals (•OH) [8].
To counteract oxidative and nitrosative stress, cells employ a large
panel of enzymatic and non-enzymatic defense mechanisms [8].
Stress occurs when the net ﬂux of ROS/RNS production exceeds theEnzyme Commission number; ER, endoplasmic reticulum; FAO, fatty acyl-CoA oxidase;
tathione; NFKB1, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;
; PTS1, C-terminal peroxisomal targeting signal; RNS, reactive nitrogen species; roGFP,
scent protein
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It is often assumed that mitochondria are the primary source of oxi-
dative stress in mammalian cells [10]. However, there is currently
no convincing experimental evidence to support this postulate [11].
In addition, the only currently available study comparing the relative
ROS production by different cellular sources demonstrated that the
endoplasmic reticulum (ER) and peroxisomes may even have a great-
er capacity to produce ROS than mitochondria, at least in rat liver
[12]. Research efforts on ER-generated oxidative stress have revealed
that the production of ROS is closely linked to protein folding [13].
Furthermore, it has been shown that chronic ER-derived oxidative
stress plays a critical role in the initiation of apoptosis and the patho-
genesis of multiple metabolic and neurodegenerative diseases [14].
Surprisingly, for a long time, little attention was paid to the impor-
tance of peroxisomes in cellular ROS/RNS homeostasis. However, in
recent years, peroxisomal ROS/RNS metabolism and signaling has be-
come an exciting and rapidly evolving multidisciplinary research ﬁeld
[15–17]. In this review, we will provide an overview of our current
knowledge on how peroxisomes contribute to the maintenance of
cellular ROS/RNS levels and how cells cope with peroxisome-
derived oxidative stress. In addition, we will highlight the present
gaps in our knowledge and outline a set of strategies that can drive
this research ﬁeld forward. Note that we will mainly focus on mam-
malian peroxisomes, although it should be emphasized that a signiﬁ-
cant portion of the pioneering work in this area was carried out in
other organisms such as yeasts [18], nematodes [19], and plants [16].
2. Peroxisomal ROS/RNS metabolism
The term ‘peroxisome’ was introduced by Nobel Laureate Christian
de Duve in 1965 to deﬁne a cell organelle which contains at least
one H2O2-producing oxidase and catalase, a H2O2-degrading enzyme
[20]. This implies that peroxisomes generate ROS as an integral fea-
ture of their normal metabolism. This is further exempliﬁed by the
fact that peroxisomes in rat liver may be responsible for as much as
20% of the oxygen consumption and 35% of the H2O2 production
[12,21]. Another indication that peroxisomes may act as endogenous
stress generators comes from the ﬁnding that a long-term adminis-
tration of peroxisome proliferators to rodents induces oxidative stress
in liver cells [22]. This is most likely due to the fact that these com-
pounds, which activate the nuclear receptor PPARα (peroxisome
proliferator-activated receptor alpha), lead to a many-fold induction
of H2O2-producing enzymes without a concomitant increase in cata-
lase activity [23]. Numerous observations indicate that peroxisomes
can also protect cells from oxidative stress. For example, the absence
of functional peroxisomes causes increased apoptosis in the develop-
ing mouse cerebellum [24]; human patients suffering from an inher-
ited deﬁciency of catalase, the most abundant peroxisomal
antioxidant enzyme, face an increased risk of developing age-
related diseases including diabetes, atherosclerosis, and cancer [25];
and mammalian cells defective in the biosynthesis of plasmalogens,
a lipid species with antioxidant activity of which the two initial
steps of biosynthesis are exclusively catalyzed by peroxisomal en-
zymes [26], are much more sensitive to ROS generated by UV-
irradiation than control cells [27,28]. These observations, among
others [15,29], support the idea that peroxisomal metabolism and cel-
lular oxidative stress are closely intertwined. In the following two
sections, we will focus on the major peroxisomal sources of ROS/
RNS (see Section 2.1.) as well as the organelle's antioxidant defense
systems (see Section 2.2.).
2.1. Peroxisomes as a cellular source of ROS/RNS species
Mammalian peroxisomes play a key role in variousmetabolic path-
ways, including fatty acidα- and β-oxidation, ether-phospholipid bio-
synthesis, glyoxylate metabolism, amino acid catabolism, polyamineoxidation, and the oxidative part of the pentose phosphate pathway
[30]. Interestingly, many of the enzymes participating in these path-
ways generate speciﬁc ROS or RNS as byproducts of their normal cat-
alytic function (Table 1) [31]. In this section, we will focus on the
different types of ROS/RNS that can be generated inside peroxisomes.
2.1.1. Hydrogen peroxide
Peroxisomes contain various enzymes that produce H2O2 as part of
their normal catalytic cycle. These enzymes, which aremainly ﬂavopro-
teins, include acyl-CoA oxidases, urate oxidase, D-amino acid oxidase,
D-aspartate oxidase, L-pipecolic acid oxidase, L-α-hydroxyacid oxidase,
polyamine oxidase, and xanthine oxidase. For a detailed description of
these enzymes, we refer to an excellent recent review covering this
topic [31].
2.1.2. Superoxide- and nitric oxide radicals
Peroxisomes contain two potential enzymatic sources of O2•− and
NO•, namely xanthine oxidase and the inducible form of nitric oxide
synthase. Xanthine oxidase (XDH) is an enzyme that produces H2O2
(see Section 2.1.1.) and O2•− as byproducts of its catalytic cycle [32].
In addition, this enzyme can also reduce nitrates and nitrites to NO•
[33]. The inducible form of nitric oxide synthase (NOS2) is a homodi-
meric enzyme that catalyzes the oxidation of L-arginine to NO• and cit-
rulline in a complex reaction requiring O2, NADPH, tetrahydrobiopterin
(BH4), FMN, and FAD [16]. Interestingly, in the absence of adequate
substrate or when in its monomeric form, the enzyme can also produce
signiﬁcant amounts of O2•− [34]. The precise subcellular localization of
NOS2 remains enigmatic and can vary depending on the cell type and
the environment of the cell [35]. Localization studies of NOS2 have
shown that this protein displays a dual cytosolic-peroxisomal localiza-
tion in hepatocytes [35,36]. Interestingly, although themolecularmech-
anisms underlying NOS2 targeting to peroxisomes remain to be
determined, it has been shown that the peroxisomal pool of NOS2
mainly consists of ‘inactive’monomers while the cytosolic pool is com-
posed of both monomers and ‘active’ homodimers [36]. These ﬁndings,
in combination with the observation that monomeric NOS2 can gener-
ate O2•−, led to the hypothesis that NOS2 might be sequestered by per-
oxisomes to protect the larger cellular environment from monomeric
NOS2-generated superoxide [36]. Nevertheless, at the moment, it can-
not be rigorously excluded that – under certain circumstances – perox-
isomal NOS2 may also actively produce NO• and function as a source of
RNS signaling molecules.
2.1.3. Hydroxyl radical and peroxynitrite
Currently, there is no evidence that mammalian peroxisomes con-
tain enzymes that produce •OH or ONOO−. However, as already men-
tioned in the Introduction, H2O2 inside peroxisomes may give rise to
•OH through the Fenton reaction. In addition, as (i) these organelles
contain enzymatic sources of O2•− and NO• (see Section 2.2.2.), and
(ii) the reaction of NO• with O2•− to form ONOO− is kinetically and
thermodynamically favored [37], it is very likely that peroxisomes
also generate ONOO−.
2.2. The peroxisomal antioxidant defense system
Mammalian peroxisomes contain various ROS metabolizing en-
zymes, including catalase, superoxide dismutase 1, peroxiredoxin 5,
glutathione S-transferase kappa, ‘microsomal’ glutathione S-
transferase, and epoxide hydrolase 2 (Table 2). In addition, there is
some evidence that these organelles also employ non-enzymatic
low molecular weight antioxidant compounds. Each of these antioxi-
dant defense systems will be discussed in more detail below.
2.2.1. Catalase
Catalase (CAT) is a homotetrameric heme-containing enzyme that
can remove H2O2 in a catalatic (2 H2O2→2 H2O+O2) or peroxidatic
Table 1
Human peroxisomal enzymes that produce ROS/RNS as byproducts of their normal
catalytic activity.
Name Protein
symbol
EC
number
ROS/RNS PTS Localization
Acyl-CoA oxidase 1 ACOX1 1.3.3.6 H2O2 PTS1 PO
Acyl-CoA oxidase 2 ACOX2 1.3.3.6 H2O2 PTS1 PO
Acyl-CoA oxidase 3 ACOX3 1.3.3.6 H2O2 PTS1 PO
D-amino acid oxidase DAO 1.4.3.3 H2O2 PTS1 PO
D-aspartate oxidase DDO 1.4.3.1 H2O2 PTS1 PO
L-pipecolic acid
oxidase
PIPOX 1.5.3.1 H2O2 PTS1 PO
L-α-hydroxyacid
oxidase 1
HAO1 1.1.3.15 H2O2 PTS1 PO
L-α-hydroxyacid
oxidase 2
HAO2 1.1.3.15 H2O2 PTS1 PO
Polyamine oxidase PAOX 1.5.3.13 H2O2 PTS1 PO
Xanthine oxidase XDH 1.17.1.4 H2O2, NO•, O2•− U PO/C/MT
Inducible nitric
oxide synthase
NOS2 1.14.13.39 NO•, O2•− U C/PO
C, cytosol; MT, mitochondria; PO, peroxisomes; U, unknown.
Table 2
Human peroxisomal antioxidant enzymes.
Name Protein
symbol
EC
number
Substrate PTS Localization
Catalase CAT 1.11.1.6 H2O2 PTS1 PO/C?
Superoxide
dismutase 1
SOD1 1.15.1.1 O2•− PM C/MT/PO/N
Peroxiredoxin 5 PRDX5 1.11.1.15 ONOO−, ROOH,
H2O2
PTS1 C/MT/PO/N
GST kappa 1 GSTK1 2.5.1.18 U PTS1 PO
Microsomal GST 1 MGST1 2.5.1.18 U U ER/MT/PO
Epoxide hydrolase 2 EPHX2 3.3.2.10 Epoxides PTS1 PO/C
C, cytosol; ER, endoplasmic reticulum; GST, glutathione S-transferase; MT, mitochon-
dria; N, nucleus; PM, piggyback mechanism (for more information, see Section 2.2.2.);
PO, peroxisomes; U, unknown (for more information, see Section 2.2.4.).
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include – among others – alcohols, formate, and nitrite [38]. Mamma-
lian catalase can also act as an oxidase, using O2 when H2O2 is absent
[39]. Among the substrates identiﬁed for this oxidase action are in-
dole, β-phenylethylamine, and various carcinogens and anticarcino-
gens [38]. Catalase is one of the most abundant peroxisomal
proteins within mammalian cells. It contains a non-canonical
C-terminal peroxisomal targeting signal (PTS1) and is targeted to the
organelle by PEX5, the PTS1-import receptor [40]. However, in certain
cell types or under certain conditions, catalase may also be (partially)
localized to the cytosol and the nucleus [41,42]. The exact physiological
function of catalase is not yet completely understood. Its predominant
role is most likely to prevent the accumulation of toxic levels of H2O2.
This may in turn prevent the formation of hydroxyl radicals by the Fen-
ton reaction. The oxidatic and peroxidatic activities of catalase may
serve to metabolize and/or detoxify small molecular weight electron
donors. For example, it is well-established that in brain, the catalase-
mediated oxidation of ethanol is an important source of acetaldehyde,
a compound involved in the behavioral and neurotoxic effects of etha-
nol in humans [43,44]. Intriguingly, despite these apparently important
functions, catalase activity is not essential for life. Indeed, catalase null
mice develop normally and do not display any gross physical or behav-
ioral abnormalities [45]. Nevertheless, tissues from these mice show a
differential sensitivity to oxidant injury and exhibit a retarded rate in
consuming extracellular H2O2 [45].
2.2.2. Superoxide dismutase 1
Superoxide dismutase 1 (SOD1) is a homodimeric enzyme that
can convert O2•− to O2 and H2O2 (2 O2•−+2 H+→O2+H2O2). The
protein, which can also be found in the cytosol, the nucleus, and mi-
tochondria, is imported into peroxisomes via a piggyback mechanism
in complex with ‘copper chaperone for SOD1’, a PTS1-containing
physiological interaction partner [46]. Currently, it is postulated that
SOD1 and catalase comprise a short metabolic route protecting cells
from damage by ROS [31]. In addition, as O2•− can rapidly react
with NO• to form ONOO−, SOD1 has been suggested to play an impor-
tant role in the reduction of nitrosative stress [47]. Interestingly, mu-
tations in the SOD1 gene account for approximately 20–25% of the
patients with familial amyotrophic lateral sclerosis [48]. It has also
been shown that transgenic mice containing an extra copy of the
human SOD1 gene display a similar phenotype to Down syndrome,
including neurological defects and premature aging [49].
2.2.3. Peroxiredoxin 5
Peroxiredoxin 5 (PRDX5) is a thiol-dependent monomeric perox-
idase that can reduce H2O2 to H2O, alkyl hydroperoxides (ROOH) totheir respective alcohols (ROH), and ONOO− to nitrite (ONO−) [50].
The reducing equivalents needed for these reactions are thought to
be provided by thioredoxins (TRXs), a group of small, multifunctional
proteins that act as antioxidants by facilitating the reduction of other
proteins by cysteine thiol-disulﬁde exchange [51]. Interestingly,
human PRDX5 has been shown to react much faster with ONOO−
(~107 M−1 s−1) and ROOH (~106 M−1 s−1) than with H2O2
(~105 M−1 s−1) [52]. In addition, this enzyme has been found in dif-
ferent subcellular compartments including the cytosol, the nucleus,
mitochondria and peroxisomes [53]. Currently, it is well-established
that mammalian PRDX5 is targeted to peroxisomes by virtue of a
PTS1 targeting signal [54]. The exact function of this protein inside
peroxisomes is not yet known. On one hand, it is thought that
PRDX5 may assist catalase in the removal of H2O2. However, based
on the measured rate constants, it is more likely that the enzyme
functions in the detoxiﬁcation process of peroxynitrite and lipid per-
oxides [50]. Finally, it should be noted that the physiological electron
donor for PRDX5 in the peroxisomal matrix remains to be identiﬁed.
2.2.4. Glutathione S-transferase kappa and microsomal glutathione
S-transferase 1
Glutathione S-transferases (GST) are a superfamily of enzymes
that catalyze the conjugation of xenobiotics and potentially damaging
oxidative metabolites with glutathione [55]. Currently, there is some
evidence that both glutathione S-transferase kappa (GSTK1) and ‘mi-
crosomal’ glutathione S-transferase 1 (MGST1) are at least partially
located in peroxisomes [56,57]. Both enzymes have also been found
in mitochondria, and – as can be deduced from its name – MGST1 is
also present in the ER [58,59]. The peroxisomal localization of
GSTK1, which is a soluble homodimeric enzyme, depends on a PTS1
sequence [56]. How the membrane-bound homotrimeric protein
MGST1 is targeted to peroxisomes is not yet known [57]. The exact
functions of GSTK1 and MGST1 within peroxisomes remain to be
established. However, based on their in vitro activities, it has been
suggested that these proteins may play an important role in the de-
toxiﬁcation of xenobiotic compounds and lipid peroxide products
[31,57].
2.2.5. Epoxide hydrolase 2
Epoxide hydrolase 2 (EPHX2) is a homodimeric enzyme that can
bind epoxides and convert them to the corresponding dihydrothiols
[60]. The protein, found in both the cytosol and peroxisomes, contains
a relatively weak PTS1 targeting signal [61]. Currently, it is thought
that the main physiological role of EPHX2 is to detoxify fatty-acid de-
rived epoxides [62]. Interestingly, certain polymorphisms in the
human gene are associated with an increased risk of atherosclerosis
and cardiovascular diseases [63].
2.2.6. Low molecular weight antioxidants
Free radicals can also be scavenged by non-enzymatic low molec-
ular weight antioxidants. These compounds, which are either water-
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diet [64]. The low molecular weight antioxidants that will be dis-
cussed in more detail below include glutathione, ascorbic acid, and
plasmalogens.
Glutathione, a cysteinyl tripeptide, is one of the most prevalent
and important redox buffers of the cell [65]. The molecule can exist
in either a reduced (GSH) or oxidized (GSSG) state. GSH, the biologi-
cally active form, can participate in numerous redox reactions and is
oxidized to GSSG during oxidative and nitrosative stress conditions
[7]. GSSG is reduced back to GSH by an NADPH-dependent glutathi-
one reductase (GR, EC 1.8.1.7). Currently, it is widely accepted that
the GSH/GSSG ratio reﬂects the redox capacity of a cell [66]. Never-
theless, it is also clear that the GSH/GSSG redox couple functions in
conjunction with redox proteins such as TRXs and glutaredoxins
(GRXs) [5]. GSH is exclusively synthesized in the cytosol, from
where it is transferred into other cellular compartments [65].Whether
or not peroxisomes contain a functional glutathione redox system is
not yet clear. For example, there is some evidence that GSHmay freely
penetrate the peroxisomal membrane through PXMP2, a non-
selective pore-forming protein with an upper molecular size limit of
300–600 Da [67]. In addition, it has been shown that roGFP2, a
genetically-encoded probe that senses changes in the glutathione
redox potential via GRX [68], responds quickly and reversibly to
redox changes in the peroxisomal matrix (for more details, see
Section 3.1.1.) [69]. However, it remains to be investigated how oxi-
dized roGFP2 and GSSG are reduced inside the peroxisomal matrix,
and – in case the organelles would completely lack glutathione reduc-
tase activity – how GSSG is exported back into the cytosol.
Ascorbic acid (vitamin C) is a water-soluble dietary supplement
that can act as cofactor and antioxidant [70]. In peroxisomes, the
compound has been reported to be necessary for maximal activity
of phytanoyl-CoA 2-hydroxylase, a peroxisomal α-oxidation enzyme
that catalyzes the 2-hydroxylation of 3-methyl-branched acyl-CoAs
[71]. Whether or not ascorbic acid also has an antioxidant function in-
side mammalian peroxisomes is less clear. Indeed, it has recently
been demonstrated that cultivating mammalian cells in the pres-
ence of ascorbic acid actually results in an increased redox state of
the peroxisomal matrix [69]. This may be explained by the combined
ﬁndings that (i) peroxisomes contain relatively large amounts of
heme- and non-heme iron-containing enzymes [72], and (ii) ascorbic
acid can reduce transitionmetals, and this may in turn lead to the gen-
eration of free radicals through the Fenton reaction [70].
Another interesting group of non-enzymatic antioxidants may be
plasmalogens. Indeed, albeit the physiological function of this speciﬁc
class of glycerolipids is still poorly understood, there is currently good
evidence that these molecules – which are produced from
peroxisome-derived intermediates – may act as radical scavengers
[26]. For example, it has been shown that plasmalogens are able to
protect unsaturated membrane lipids against oxidation by singlet ox-
ygen without producing oxidation products that are excessively toxic
[73]. In addition, cells deﬁcient in peroxisome assembly and/or plas-
malogen biosynthesis are several orders of magnitude more sensitive
to UV-induced ROS production than control cells [27].
3. Detection and modulation of the peroxisomal redox state
Over the years, various experimentalmodel systems have been used
to gain a better insight into the physiological role of peroxisomal ROS/
RNS metabolism and signaling. In this section, we will provide an over-
view of the strategies that have been successfully employed in the past.
In addition,wewill highlight some recent advances in the research area
of oxidative stress and discuss how these developments may open new
avenues in the ﬁeld of peroxisome research. In this context, it is also in-
teresting to note that, although peroxisomes are densely populated
with oxidative enzymes, these organellesmaintain a reduced redox en-
vironment [69,74]. Whether or not this environment is more reducingthan that of the cytosol or mitochondria depends on the cell type (e.g.
ﬁbroblasts versus pancreatic β-cells) and culture conditions (e.g. low
or high concentrations of ascorbic acid, serum, and/or glucose) ([69];
Lemaire and Fransen, unpublished results).
3.1. Detection of peroxisomal ROS/RNS
During the past decade, many probes have been developed to
measure oxidative stress in both live and ﬁxed cells. These probes
can largely be grouped into three different classes: (i) compounds
and reagents that can be used to detect irreversible oxidative modiﬁ-
cations (e.g. protein carbonylation) [2]; (ii) chemical ﬂuorescent and
luminescent probes for the detection of reactive oxygen and nitrogen
species [75]; and (iii) proteinaceous reporter molecules [76]. Here we
will focus in more detail on the genetically-encoded ﬂuorescent im-
aging probes which have recently gained a lot of interest for multiple
reasons: (i) they offer the possibility to append organelle-speciﬁc tar-
geting signals and to perform noninvasive compartment-speciﬁc
measurements; (ii) they are reversible and can be used to quantify
transient redox changes; and (iii) they are ratiometric by excitation,
thus minimizing measurement errors resulting from probe concen-
tration, probe distribution, and cell thickness [77]. These are all im-
portant requirements to detect ROS/RNS with a high degree of
spatial and temporal resolution.
3.1.1. Redox-sensitive green ﬂuorescent proteins
Redox-sensitive green ﬂuorescent proteins (roGFPs) are currently
the most commonly used probes for monitoring the organellar redox
state in living cells.Members of this class of proteins contain engineered
cysteine residues on adjacent surface-exposed β-strands that form a di-
sulﬁde bond under oxidizing conditions [78]. As oxidation of the dithiol
pair causes reciprocal changes in emission intensity when excited at
~400 and ~490 nm, the ratio of roGFP emissions (at ~510 nm) can pro-
vide a non-destructive read-out of the redox environment of the ﬂuor-
ophore [77,78]. RoGFPs preferentially interact with GRXs, indicating
that these probes most likely equilibrate with the local glutathione
redox potential [79]. As distinct subcellular compartments often have
different redox environments, various roGFPs with different reduction
potentials of the disulphide have been developed [68,80]. We have re-
cently shown that roGFP2 is a suitable probe to monitor redox changes
in the peroxisomal matrix in living cells [69].
3.1.2. HyPer
HyPer is a ratiometric probe speciﬁcally developed to detect H2O2
[81]. The protein, which consists of a circularly permutated yellow
ﬂuorescent protein inserted into the regulatory domain of a prokary-
otic H2O2-sensing protein, contains two cysteine residues that are
speciﬁcally oxidized by H2O2, but not by O2•−, ONOO−, and GSSG
[82,83]. HyPer exhibits two excitation peaks at ~420 and ~500 nm
and one emission peak at ~516 nm. Rise in H2O2 concentration results
in a decrease in the 420 nm excitation peak and a proportional in-
crease in the 500 nm excitation peak [81]. Interestingly, the half max-
imal effective concentration of HyPer for H2O2 is ±8 μM, which is
almost 25 times less than that of roGFP [83]. A potential disadvantage
of this probe is that it is rather pH-sensitive [81]. Recently, HyPer has
been used to demonstrate that H2O2 produced inside peroxisomes is
an important mediator of lipotoxicity in insulin-producing cells [84].
3.1.3. Redoxﬂuor
Redoxﬂuor is a recently developed ﬂuorescence resonance energy
transfer (FRET)-based probe that can sense the redox potential of glu-
tathione via its internal disulﬁde bonds [74]. The protein contains a
tandem repeat of a partial region within the carboxy-terminal
cysteine-rich domain of Yap1, a transcription factor crucial for oxida-
tive stress response in Saccharomyces cerevisiae, and mediates FRET
between cerulean, a variant of the cyan ﬂuorescent protein (CFP),
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oxidation, CFP emission is enhanced at the expense of YFP emission,
thereby decreasing the yellow-to-cyan emission ratio (527/476 nm).
Recently, this probe has been successfully used to develop an efﬁcient
screening system for redox modulators that can restore the redox sta-
tus in mammalian cell lines with defective peroxisome assembly
without affecting the redox status of normal cells [74].
3.2. Modulation of the peroxisomal redox state
To gain a better insight into how cells respond to peroxisome-
derived oxidative stress, it is essential to have access to model sys-
tems in which the peroxisomal redox status can be selectively
modulated in a controllable manner. Here we will discuss some of
the strategies that have already been successfully used to manipu-
late peroxisome-derived oxidative stress in mammalian cells. Note
that, although these studies clearly indicate that peroxisomes may
constitute a cellular source of ROS/RNS, none of these strategies
has yet been employed to study the corresponding cellular re-
sponses at the molecular level.
3.2.1. Peroxisome proliferators and fatty acids
Already more than a decade ago, several studies reported that the
peroxisomal redox balance can be disturbed by the selective activa-
tion of peroxisomal metabolism. For example, after Reddy and col-
leagues discovered that the administration of peroxisome
proliferators to rodents can induce liver cancer [86], they also studied
the effect of such a treatment on oxidative stress and found a dispro-
portionate increase in H2O2-producing enzymes and catalase [22,87].
Other studies showed that (i) mammalian cells stably overexpressing
peroxisomal fatty acyl-CoA oxidase (FAO) became neoplastic upon
exposure to a fatty acid substrate for 2–6 weeks [88,89], (ii) a tran-
sient overexpression of peroxisomal FAO in Cos-1 cells led to nuclear
NFKB1 DNA binding activity in a dose-dependent manner [90],
and (iii) a chronic exposure of pancreatic β-cells to long-chain
non-esteriﬁed fatty acids increased peroxisomal H2O2-production,
ultimately leading to β-cell death [91]. In summary, these ﬁndings de-
monstrate that it is technically possible to induce peroxisomal oxida-
tive stress in intact cells by stimulating the organelle's metabolism.
3.2.2. Catalase activity
As catalase is the most abundant antioxidant enzyme in mamma-
lian peroxisomes, it represents an attractive target to modulate the
organelle's antioxidative stress system in intact cells. Several
completely different approaches have already been used for this pur-
pose. Perhaps the most straightforward way is to incubate the cells
with 3-amino-1,2,4-triazole (3-AT), a well-characterized irreversible
inhibitor of catalase [92]. At non-cytotoxic dosages, such a treatment
may decrease catalase activity by ±70% [93]. Alternatively, one may
employ genetically modiﬁed cells (e.g. from transgenic or knockout
mice) [45,94], vector-driven expression systems [69,95], or even
cell-penetrating catalase derivatives [96,97]. In this context, it is in-
teresting to mention that both reducing and increasing catalase activ-
ity may make cells more vulnerable to different types of oxidative
stress [94,96]. These ﬁndings indicate that nonlethal concentrations
of H2O2 may exert net beneﬁcial effects on the cell, and that catalase
overexpression may interfere with the potential signaling mecha-
nisms of H2O2 [94]. The effects of altered catalase activities on
human health will be discussed in Section 6.
3.2.3. Other (potential) strategies
Another strategy that has already been successfully employed to
selectively produce oxidative stress inside peroxisomes is the use of
KillerRed, a genetically-encoded photosensitizer which produces rad-
icals and H2O2 upon green light illumination [98,99]. By using a per-
oxisomal variant of this protein, we recently found that excessiveROS production inside peroxisomes may disturb the mitochondrial
redox balance, and this can in turn lead to mitochondrial fragmenta-
tion [69]. An alternative method that may be better suited for bio-
chemical investigations are transgenic cells overexpressing D-amino
acid oxidase, a bona ﬁde peroxisomal matrix protein [100]. Indeed,
a nuclear targeted version of this protein has already successfully
been used to study the effects of nuclear localized oxidative stress
[101]. In addition, it is most likely easier to control the production
of H2O2 in a D-amino acid-regulatable system than in a peroxisome
proliferator- or free fatty acid-dependent system. Finally, one may
consider altering the activities of other peroxisomal antioxidant en-
zymes. However, as most of these enzymes are located in multiple
cellular compartments (see Section 2.2.), it is virtually impossible to
study the peroxisome-speciﬁc effects on the cellular phenotype by
knocking down their expression (e.g. through RNA interference).
Nevertheless, one may solve this problem, at least partially, by artiﬁ-
cially targeting these enzymes to peroxisomes by the use of a strong
PTS1 (see Section 4.3.2).
4. Targets of peroxisomal ROS/RNS
Peroxisomes may potentially function as an intracellular source of
H2O2, O2•−, •OH, NO•, and ONOO− (see Section 2.1.). These small re-
active molecules have distinct biological properties resulting from
their chemical reactivity, half-life, and lipid solubility (Table 3). For
example, the •OH radical is highly reactive and therefore reacts very
close to the site of its production. The half-life of H2O2 is much longer,
and this molecule has preferred biological targets [102]. The range of
ROS/RNS action is co-determined by their free aqueous diffusion dis-
tances [103]. This distance may vary depending on the action of ROS/
RNS scavengers, their solubility in lipids, and the membrane perme-
ability of the organelle in which these molecules are produced. In
this context, it is important to note that peroxisomes are densely pop-
ulated with antioxidant enzymes (see Section 2.2.), and that the
peroxisomal membrane contains porin-like channels which may fa-
cilitate the transit of ROS/RNS from the peroxisomal matrix to the
cytosol (and vice versa) [67].
4.1. Peroxisomal matrix proteins
Oxidative and nitrosative stress can directly lead to reversible or
irreversible protein modiﬁcations. For example, H2O2 may oxidize
cysteine sulfhydryl groups to form disulﬁde bridges, sulfenic acids,
or sulﬁnic acids; NO• may react with sulfhydryls to yield S-
nitrosothiols; and other redox-based protein modiﬁcations may in-
clude hydroxylations, carbonylations, nitrosylations, and the destruc-
tion of iron–sulfur clusters [2].
Previous studies have shown that chronically reducing catalase ac-
tivity in mammalian cells to approximately 38% of normal, increased
the levels of carbonylated proteins, and particularly in the peroxisome-
enriched organelle fraction [93]. This may be a surprising observation
given that H2O2, the substrate of catalase, is not particularly reactive to-
ward biological molecules. However, as transition metals such as iron
are abundantly present in peroxisomes, the accumulation of H2O2
most likely results in the generation of highly reactive hydroxyl radicals
via the Fenton reaction (see Section 1.). Note that protein carbonylation
is considered to be an irreversible posttranslationalmodiﬁcation [2], and
the effects of this modiﬁcation on peroxisome function are not yet clear.
However, in order to preserve organelle function, these oxidatively
damaged proteins aremost likely proteolytically removed by the perox-
isomal Lon protease [104,105].
It is also thought that, within the peroxisomal matrix, NO• can com-
bine with O2•− to form ONOO−, a strong oxidizing and nitrating agent
that may inactivate peroxisomal enzymes [16,35]. For example, NO•
andONOO− can rapidly reactwith the heme group of catalase and inac-
tivate the enzyme [16]. This may in turn promote overproduction of
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nitrosoglutathione (GSNO), a long distance signal molecule. It has
been hypothesized that peroxisomal GSNO may act as a powerful in-
ducer of defense genes in plants [16]. The potential function of peroxi-
somal GSNO in mammalian cells, if any, is not yet clear.
4.2. The peroxisomal membrane
Currently, it is widely accepted that polyunsaturated fatty acids,
which are important lipid constituents in biological membranes, are
key targets for strong oxidants such as •OH and ONOO− [106]. The
corresponding damage, called lipid peroxidation, may have profound
effects on membrane ﬂuidity, membrane permeability, and the activ-
ity of membrane-bound enzymes and receptors [3]. In addition, lipid
peroxidation breakdown products (e.g. 4-hydroxynonenal) may act
as second messengers of oxidative stress in autophagy, apoptosis,
and cell proliferation signaling pathways [106]. At the moment, sur-
prisingly little is known on the potential role of oxidative stress-
induced lipid peroxidation in mammalian peroxisomes. Nevertheless,
it is tempting to speculate that peroxisomes with oxidatively dam-
aged membranes are selectively removed by autophagy. How this
may occur, remains to be investigated.
4.3. The extraperoxisomal environment
Early studies with isolated rat liver peroxisomes have revealed
that 20–60% of the H2O2 generated inside peroxisomes diffuses to
the surrounding medium [12]. This ﬁnding demonstrates that H2O2
can rapidly cross the peroxisomal membrane, most likely through
the recently identiﬁed porin-like channel [67]. In addition, a more re-
cent study has shown that – in intact rat liver peroxisomes – H2O2
generated by the core-localized urate oxidase is directly released in
the cytoplasm via crystalloid core tubules [107]. Together, these ﬁnd-
ings indicate that peroxisomes are not able to prevent the release of
intraperoxisomal H2O2, despite their high content of catalase. As
these organelles also contain enzymatic sources of membrane-
permeant NO• (see Section 2.2.2.), it is highly likely that – at least
under certain physiological or pathological conditions – peroxisomes
may act as a cellular source of both H2O2 and NO• in living cells. Nev-
ertheless, very little is currently known about how, and to what ex-
tent, these peroxisome-derived small reactive molecules contribute
to cellular redox homeostasis and redox signaling. NO• is thought to
act through its primary receptor, guanylyl cyclase, which upon activa-
tion produces cyclic GMP, another second messenger [1]. Other intra-
cellular targets of this reactive nitrogen species may include Fe2+-
containing proteins and reactive protein thiols [108]. H2O2 is thought
to signal through the chemoselective oxidation of deprotonated cys-
teine residues in target proteins [109]. In addition, this molecule
may react with Fe2+-containing cofactors found in a select set of pro-
teins [109]. In this section, we will focus on how peroxisome-derived
oxidative stress may activate various redox-sensitive signaling path-
ways. For a link between peroxisomal ROS/RNS production and
human disease, we refer to Section 6.Table 3
Chemical properties of ROS/RNS produced in peroxisomes.a
Name Formula Biological half-lifeb Membrane-permeabilityc
Hydrogen peroxide H2O2 ~10−5 s Very low
Superoxide radical O2•− ~10−6 s Very low
Hydroxyl radical •OH ~10−9 s Very low
Nitric oxide radical NO• b1 s High
Peroxynitrite ONOO− ~1 s Very low
a These data were compiled from [37,83,103,158–160].
b These values may be strongly inﬂuenced by local antioxidant activities.
c These results have been obtained with artiﬁcial lipid membranes.4.3.1. Peroxisomal ROS production and nuclear gene expression
The intracellular localization and activity of numerous signaling
proteins and transcription factors are, directly or indirectly, con-
trolled by the oxidation of thiol groups of redox-sensitive cysteine
residues [9,110]. For example, it has been shown that some transcrip-
tion factors (e.g. nuclear factor (erythroid-derived 2)-like 2) possess
reversibly oxidizable cysteines in their active site, and that – upon ex-
posure to ROS – their sulfhydryl groups are oxidatively modiﬁed,
which may cause their nuclear translocation and lead to enhanced
cytoprotective gene expression [111,112]. Currently, there is strong
evidence that peroxisomal H2O2 may function as an important modu-
lator of NFKB1, a pleiotropic transcription factor that is involved in
many biological processes, including inﬂammation, immunity, differ-
entiation, cell growth, tumorigenesis, and apoptosis [113]. For
example, it has been reported that a transient overexpression of the
H2O2-producing peroxisomal enzyme FAO resulted in a
concentration-dependent DNA binding activity of NFKB1 DNA in
Cos-1 cells, and that this phenomenon could be counteracted by over-
expression of catalase [90]. In addition, it has been shown that a ge-
netic or pharmacological inactivation of catalase in mouse
neutrophils inhibited the nuclear accumulation of NFKB1 and the pro-
duction of the proinﬂammatory cytokines TNF-α and MIP-2 [114].
Note that, to make sense of these apparently conﬂicting data, it is im-
portant to know that – depending on the cell type and the experi-
mental conditions – H2O2 may stimulate or inhibit the NFKB1
activation pathway [115]. Despite this, these data clearly show that
the production of H2O2 inside peroxisomes can affect nuclear gene
expression. As the peroxisomal localization of NOS2 has been associ-
ated with a reduced expression level of catalase in hepatocytes [35],
the same might be true for peroxisomal NO• production. However,
note that – as (i) only a fraction of NOS2 is localized in peroxisomes
(see Section 2.1.2.), and (ii) it is not yet clear whether or not peroxi-
somal NOS2 effectively produces NO• (see Section 2.2.2.) – this re-
mains to be investigated in more detail.
4.3.2. Redox communication between peroxisomes and mitochondria
Peroxisomes and mitochondria exhibit a functional interplay that
continues to emerge [116,117]. Over the past years, it has become
clear that these organelles also share a redox-sensitive relationship.
For example, it has been shown that catalase-SKL, a catalase deriva-
tive with enhanced peroxisome targeting, can efﬁciently repolarize
mitochondria in late passage cells [118]. In addition, we recently
found that the mitochondrial redox balance is disturbed in cells lack-
ing catalase or functional peroxisomes, and upon the generation of
excess ROS inside peroxisomes [69; Apanasets and Fransen, unpub-
lished results]. On the other hand, peroxisomes were found to resist
oxidative stress generated inside mitochondria [69]. In summary,
these ﬁndings suggest that peroxisome-derived oxidative stress may
trigger signaling/communication events that ultimately result in in-
creased mitochondrial stress. The molecular mechanisms underlying
this phenomenon remain unclear. A number of molecules may partic-
ipate in linking these organelles. For example, peroxisomes initiate
oxidative metabolism of speciﬁc fatty acids which are then trafﬁcked
to mitochondria where processing is completed [119]. The organelles
also communicate via anaplerotic metabolism [17]. It can be envi-
sioned that as peroxisomal metabolism is slowed down, critical met-
abolic intermediates (e.g. acetyl-CoA) are not properly produced and
trafﬁcked to mitochondria [69]. If mitochondrial metabolism is simi-
larly disrupted, an increase in uncoupled reactions and ROS produc-
tion can certainly be anticipated. There also exists the mitochondrial
retrograde signaling pathway, a process involving multiple factors
that sense mitochondrial dysfunction and transmit signals to the nu-
cleus to affect gene expression [120]. The protein products of these
genes promote, among other processes, peroxisomal β-oxidation
and peroxisome proliferation [17]. Finally, the organelles may also in-
teract via reactive oxygen species.
1369M. Fransen et al. / Biochimica et Biophysica Acta 1822 (2012) 1363–13735. Peroxisomes as targets of oxidative stress
Currently, little is known about how peroxisomes cope with oxi-
dative stress. In this section, we will discuss the pros and cons of
these organelles as a sink for cellular ROS as well as how cellular
ROS may affect peroxisome biology and function.
5.1. Peroxisomes as a sink for cellular ROS
The very high content of catalase inside peroxisomes led to the
experimentally-based prediction that these organelles may serve as
an intracellular sink for H2O2 [121]. This prediction is in line with
the ﬁndings that hypocatalasemic ﬁbroblasts accumulate H2O2 and
are oxidatively damaged [122], and that overexpression of catalase
in pancreatic islets of transgenic mice produced a marked protection
of islet insulin secretion against H2O2 [123]. However, as already dis-
cussed in Section 4.3., other studies strengthen the notion that perox-
isomes rather represent a potential source of oxidative stress, which
may cause damage to the cell or modulate redox-sensitive pathways
[107,124]. Taken together, these apparently conﬂicting observations
illustrate that caution must be taken when studying the potential
contribution of peroxisomal ROS metabolism to cellular redox ho-
meostasis. In this context, it may also not be that difﬁcult to envision
that this contribution may display strong plasticity under different
physiological and pathological conditions.
5.2. Effects of cellular ROS on peroxisome biology and function
Currently, there is substantial evidence that peroxisome number
and morphology can drastically change upon exposure of cells to var-
ious conditions of oxidative stress. For example, both UV-irradiation
and a pharmacological depletion of cellular GSH induce extensive
peroxisome elongation in mammalian cells [15,29]. In addition, it
has been reported that the number of peroxisomes drastically in-
creases while cells age, a process associated with an increase in sys-
temic oxidative stress [42,125]. The underlying mechanisms and the
functional signiﬁcance of these ﬁndings are still largely unknown.
However, it has been established that the PEX5-mediated import
pathway into peroxisomes is – at least partially – functionally im-
paired in cells experiencing oxidative stress conditions [42,126].
This manifests itself primarily in the accumulation of PEX5 at the per-
oxisomal membrane and a partial mislocalization of catalase to the
cytosol [42]. As (i) monoubiquitination of PEX5 at a conserved cyste-
ine residue (e.g. Cys11 in human PEX5) is a requisite for its ATP-
dependent export back into the cytosol [127], and (ii) shifting the cy-
tosolic redox balance back to a more reduced state restores PTS1
import in late passage cells (Apanasets and Fransen, unpublished re-
sults), it is tempting to speculate that the Cys11 in PEX5 may act as a
functional redox switch thereby regulating the peroxisomal/cytosolic
localization of peroxisomal proteins such as catalase. Such a mecha-
nism may allow cells to rapidly respond to oxidative stress in the
cytosol [128]. With respect to the relationship between peroxisome
number and oxidative stress, it has been suggested that cellular
aging may somehow alter the regulation of peroxisome growth
and division, leading to organelle proliferation in the absence of
normally required cellular cues [42]. However, as mammalian per-
oxisomes are mainly degraded via macroautophagy [129–131] and
the rate of autophagy slows with age [132], it can currently not be
ruled out that the accumulation of peroxisomes in aging cells is an
indirect result of reduced autophagy.
6. Peroxisomal ROS metabolism and human disease
It is currently a common belief that alterations in the cellular redox
state impose a considerable risk for the development of various diseases
[6]. As (i) the intracellular redox status is inherently linked to cellularmetabolism, and (ii) peroxisomes regulate major ﬂuxes of primary
and secondary metabolites, it may not be surprising to see that also
these organelles are increasingly recognized as being involved in
human pathologies related to oxidative stress. In this context, it is inter-
esting to note that – for example – compromised catalase activity has al-
ready been associated with ischemia-reperfusion injury, hypertension,
skin pigmentation disorders, retinal disease, degenerative joint disease,
heart failure, type 2-diabetes, neurodegenerative disorders, and the ini-
tiation andprogressionof certain cancers ([93]; and references therein).
In addition, the protein and activity levels of this enzyme have recently
been shown to be downregulated in nasopharyngeal secretions of in-
fants with naturally acquired respiratory syncytial virus infections
[133]. In this section, wewill highlight the potential role of peroxisomal
oxidative stress in the pathogenesis of neurodegeneration, diabetes,
aging, and cancer.
6.1. Neurodegeneration
In recent years, it has become increasingly clear that alterations in
peroxisome function may contribute to the development of neurode-
generative diseases [134]. This is best illustrated by pathomorpholo-
gical examinations of the brain of patients (and mice) in which one
or more peroxisomal functions are lost [30,134–137]. The major neu-
ropathological features of these disorders include impaired neuronal
migration, axonal degeneration, and progressive subcortical demye-
lination [136–141]. The mechanisms underlying these phenotypes,
which most likely result from a combination of facts, have not yet
been elucidated [134]. One of these pathogenic factors may be oxida-
tive stress. Indeed, it has been reported that mitochondrial SOD2, a
marker for oxidative stress, is signiﬁcantly upregulated in different
organs of peroxisome-deﬁcient mice [142]. In addition, it has been
shown that peroxisomes provide oligodendrocytes with neuroprotec-
tive and anti-inﬂammatory functions [138], and that these cells pro-
tect neuronal axons from the harmful effects of H2O2 [143]. Finally,
it has been demonstrated that a cocktail of antioxidants can halt
and even reverse axonal damage in a mouse model of X-linked adre-
noleukodystrophy, a demyelinating peroxisomal disorder [140].
6.2. Type 2-diabetes
For some time, it is known that elevated levels of long-chain and
very-long-chain saturated non-esteriﬁed fatty acids exhibit a strong
cytotoxic effect on insulin-producing β-cells [91,144]. Interestingly,
these cells contain virtually no catalase [145,146], and an elegant
study has recently demonstrated that the cytotoxic phenomenon –
referred to as lipotoxicity – is mediated by H2O2 derived from perox-
isomal β-oxidation [84]. Importantly, overexpression of catalase in
the peroxisomes and the cytosol, but not in the mitochondria, pro-
tected the cells against palmitic acid-induced toxicity [84]. In summa-
ry, these experiments led to a completely new concept in the
pathogenesis of fatty acid-induced lipotoxicity for pancreatic β-cells.
6.3. Aging
More andmore evidence indicates that peroxisomes may also play
a vital role in the chronic processes of cellular and organismal aging.
Many studies on this topic have focused on the role of catalase. None-
theless, the results are – albeit indicative – not always straightfor-
ward. For example, detailed epidemiological studies on patients
suffering from hypocatalasemia revealed an increased frequency of
age-related diseases, including – among others – type 2-diabetes, hy-
pertension, and vitiligo [147]. Despite this, mice completely lacking
catalase develop normally and are apparently healthy [45]. In addi-
tion, long-lived dwarf mice and short-lived transgenic mice exhibit
increased and decreased levels of catalase, respectively [148]. Howev-
er, transgenic mice overexpressing peroxisomal catalase do not show
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sing catalase targeted to the mitochondrial matrix display an in-
creased life expectancy by ±20% [149]. Finally, inactivation of
catalase activity has a negative impact on the mitochondrial redox
balance [69,93], a condition commonly associated with aging [150].
However, cellular aging may also compromise peroxisomal ROS me-
tabolism [42]. Importantly, a retroviral-mediated transduction of
catalase-SKL cDNA in aging cells reduced the cellular H2O2 levels
and restored mitochondrial membrane polarization [118]. In summa-
ry, these studies suggest that peroxisomes may play a physiological
role in aging. In addition, the ﬁnding that alterations in the peroxi-
somal ROS metabolism can affect the mitochondrial redox balance
[69,93,118], may have important implications for how we think
about aging and age-related diseases. In this context, it has recently
been suggested that peroxisomal ROS may not only provoke pro-
aging effects, but also function as anti-aging signaling molecules,
akin to mitochondrial ROS [17].
6.4. Cancer
Currently, there is growing evidence that peroxisomes may be ei-
ther directly or indirectly involved in cancer development. For exam-
ple, the administration of nongenotoxic peroxisome proliferators to
rodents can induce liver cancer [86,151]; hypocatalasemic mice dis-
play a higher susceptibility to spontaneous and induced tumorigene-
sis [152,153]; and peroxisome number and catalase activity are
signiﬁcantly reduced in various tumors, including colon, hepatocellu-
lar and renal cell carcinoma [154–156]. The precise mechanism of
how peroxisomes may contribute to the cancer process is not well
understood. One may envision that peroxisomal ROS/RNS may
cause permanent oxidative damage to the cell's genetic material,
which in turn may lead to genomic instability and carcinogenesis. Al-
ternatively, increased peroxisomal oxidative stress may – akin to mi-
tochondrial ROS – lead to the aberrant induction of stress-sensitive
signaling pathways that cause tumorigenesis [5].
7. Conclusions and future directions
Over the last decade, peroxisomes have emerged as potentially
important players of cellular redox metabolism. Strong arguments
have been presented that – depending on the physiological and path-
ological situation – these organelles may function as a source, a sink,
or a target of small reactive molecules. In addition, compelling evi-
dence support a direct relationship between peroxisomes and ROS/
RNS signaling. For example, high levels of peroxisomal ROS may in-
voke profound changes in gene expression; peroxisomes may act as
an upstream initiator of mitochondrial ROS signaling pathways; and
alterations in peroxisomal redox metabolism have been associated
with the etiology and progression of age-related diseases, perhaps
best exempliﬁed by cancer and type 2-diabetes. An intriguing ques-
tion that remains to be answered is how excessive levels of peroxi-
somal ROS/RNS can lead to the activation of such stress-sensitive
signaling pathways. The molecular details underpinning these re-
sponses are just beginning to emerge. However, in analogy to mito-
chondria [157], it is tempting to speculate that peroxisomal ROS/
RNS may play a signiﬁcant role in the maintenance and/or regulation
of the cellular disulﬁde proteome. In this context, it is interesting to
note that cultivating bovine aortic endothelial cells in the presence
of 3-AT increased cellular protein disulﬁde content by 20% [157]. Fu-
ture studies should focus on the identiﬁcation of the proximal targets
of peroxisomal ROS/RNS as well as on the molecular mechanisms of
how cellular ROS/RNS impinge on peroxisome function. Such studies
may provide a powerful route toward a more coherent understanding
of the mechanisms and pathways that mediate the relationship be-
tween peroxisomes and oxidative stress. This, in turn, is crucial to
gain a better insight into the physiological relevance of theseorganelles in cellular aging and the initiation and progression of
age-related diseases.
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